May 26, 2023 05:34 AM EDTUpdated 01:31 PM
Peer Review

Stephen Hahn’s can­cer-test­ing biotech hires a new CMO; For­mer Io­vance ex­ec named CEO of Ob­sid­i­an

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Andrew Dunn

Senior Biopharma Correspondent

Flag­ship Pi­o­neer­ing’s blood can­cer test­ing start­up Har­bin­ger Health has brought in drug in­dus­try vet­er­an May Or­fali as its new chief med­ical …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times